Endologix Appoints Andrew Davis as Chief Commercial Officer
Endologix LLC, a privately held global medical device company specializing in innovative therapies for vascular disease, is pleased to announce the appointment of Andrew Davis as its new Chief Commercial Officer, effective immediately.
Andrew joins Endologix with an extensive background in commercial leadership, having most recently served as the Chief Commercial Officer at Silk Road Medical where he successfully spearheaded the go-to-market strategy for a groundbreaking therapy to treat carotid artery disease (TCAR). With expertise in revenue optimization, customer engagement, and market expansion, he is poised to play a key role in advancing the company's strategic objectives.
Andy brings to Endologix over 25 years of experience in the medical device field, as well as expertise in launching innovative, minimally invasive therapies that increase patient access and solve unmet clinical needs in cardiovascular diseases. Prior to joining Silk Road Medical, Andy was the Vice President of Sales and Marketing at 3M's Advanced Wound Therapy Group. Prior to 3M, he spent 15 years at Medtronic and held various Vice President of Sales positions in Cardiac and Vascular Therapies to include TAVR, Endovascular EVAR/TEVAR, Peripheral Vascular, and Spine/Biologics. Andy received a B.S. in Political Science from Florida State University.
'We are thrilled to welcome Andrew Davis to our leadership team,' said Dr. John Liddicoat, President and Chief Executive Officer at Endologix. 'He brings a strong track record of success and innovation in the commercial space, and we are confident that his leadership will help us accelerate our growth and strengthen our market position.'
In this role, Andrew will focus on aligning commercial operations with the company's long-term vision, enhancing customer relationships, and driving new business opportunities. His leadership will be instrumental in executing Endologix's ambitious growth plans.
'I am excited to join Endologix at such a pivotal moment,' said Andrew Davis. 'I look forward to working with the talented team here to expand our market presence, drive revenue growth, and deliver exceptional value to our customers.'
About Endologix
Endologix LLC is a California-based, global medical device company dedicated to improving patients' lives by providing innovative therapies for the interventional treatment of vascular disease. Endologix's therapeutic portfolio includes a variety of products in various stages of development that are designed to treat diseases that currently have clinically relevant unmet needs. Endologix's commercial products, including the AFX®2 Endovascular AAA System, ALTO® Abdominal Stent Graft System, and the DETOUR™ System, are designed to treat a range of vascular diseases, from abdominal aortic aneurysms to lower limb peripheral vascular disease. The company has offices and manufacturing sites in Irvine, Milpitas and Santa Rosa, California. To learn more about Endologix, please visit https://www.endologix.com.
SOURCE: Endologix LLC
Copyright Business Wire 2025.
PUB: 03/03/2025 05:00 AM/DISC: 03/03/2025 05:00 AM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
33 minutes ago
- CBS News
New survey highlights how essential public transit is in Stanislaus County
A new survey from the Stanislaus Regional Transit Authority shows just how essential public transportation is for many local residents. According to the agency's fixed-route rider survey, more than 70% of passengers use the bus system at least three days a week. Two-thirds of riders report using the bus to get to work or medical appointments. The survey also highlights the financial challenges many riders face. More than half of those surveyed said they make less than $15,000 a year, while a majority report incomes under $25,000. Roughly a third are unemployed, while others are students, part-time employees, or retirees. "These are core functions. They're not just going to a ball game or running to McDonald's," said StanRTA's Angela Swanson. "These are people who are relying on the bus to stay engaged in their community and lead fruitful lives." The transit agency says data from the survey will help guide future planning and service decisions. StanRTA recently purchased three hydrogen-powered buses and is seeking additional federal funding to expand its fleet. The new buses are expected to arrive within the next year.
Yahoo
33 minutes ago
- Yahoo
Anti-DEI group targets Geisinger College of Health Sciences over program
SCRANTON — A national anti-DEI group has targeted the Geisinger College of Health Sciences with recent filings of discrimination complaints. Virginia-based Do No Harm purported in news releases in March and June that it filed separate complaints with two federal agencies against the college, citing as discriminatory its federally funded Center of Excellence for Diversity and Inclusion and a summer program that aimed to help students from Black, Hispanic or Native American communities that are underrepresented in the medical field transition into medical school. The Do No Harm discrimination complaints come amid President Donald Trump's efforts to dismantle DEI, or diversity, equity and inclusion, programs in the public and private sectors. Trump issued executive orders in the first week of his second term targeting DEI initiatives. 'Geisinger College of Health Sciences did a thorough review of our programs after the presidential executive orders were issued to ensure compliance. The pre-matriculation program referenced in the (Do No Harm) complaint ended in 2024 and is no longer active,' Geisinger CHS said in a statement. Do No Harm is labeled by the Southern Poverty Law Center as an 'anti-LGBTQ+ hate group.' Critics of the SPLC say it's politically biased and its definition of hate group is overly broad. Do No Harm first filed a complaint with the U.S. Department of Health and Human Services on March 19 against Geisinger CHS, according to a news release posted on the Do No Harm website. A member of Do No Harm then filed a similar complaint June 5 with the U.S. Department of Education, because Geisinger 'did not learn its lesson' from the initial complaint filed with HHS, the advocacy organization announced in another news release. The Times-Tribune could not verify that the complaints were filed with both departments, and whether either agency investigated the allegations or took any actions. The U.S. Department of Health and Human Services and the U.S. Department of Education through separate representatives said they do not confirm the existence of complaints. Do No Harm, established in April 2022, claims it has 17,000 members, including doctors, nurses, physicians and concerned citizens, and cites its mission as safeguarding health care from ideological threats. 'Do No Harm seeks to highlight and counteract divisive trends in medicine, such as 'Diversity, Equity and Inclusion' and youth-focused gender ideology,' the organization's website says. According to the SPLC, Do No Harm in 2024 filed eight lawsuits challenging programs such as scholarships and fellowships for marginalized people. 'The group claims that the practice of nonprofit organizations like the American Association of University Women to provide fellowships to students of color and LGBTQ+ students — groups historically underrepresented in academia and medicine — harms patients by requiring medical schools to accept or fund unqualified candidates. According to the group, the case was dismissed 'after AAUW agreed to drop the racial criteria in the fellowship's selection process,'' the SPLC website says. According to the website of Geisinger College of Health Sciences, it is the research and education arm of the Geisinger health system. Established in 2022, the college unifies the Geisinger Commonwealth School of Medicine, Geisinger School of Nursing, Geisinger School of Graduate Education, graduate medical education, Center for Faculty and Professional Development and more. * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) * Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) Show Caption 1 of 3 Geisinger College of Medicine in Scranton on Monday, June 9, 2025. (REBECCA PARTICKA/STAFF PHOTOGRAPHER) Expand
Yahoo
an hour ago
- Yahoo
Aldi Just Cut Prices on 400+ Products to Help Shoppers Save Over $100 Million This Summer
Aldi is cutting prices on over 400 items—nearly 25% of its inventory—nationwide through Labor Day to help shoppers save more than $100 million this summer. Discounts of up to 33% are being applied to popular seasonal items like fresh meat, produce, pantry staples, and snacks. The move underscores Aldi's commitment to offering everyday low prices, especially during peak grocery-spending months filled with holidays and all the recent talk about rising grocery prices, whether thanks to tariffs, supply chain issues, or other reasons, Aldi is taking steps to lessen the financial impact these price hikes are having on consumers. In fact, the Illinois-based grocer just announced that it's slashing prices on nearly 25% of its inventory ahead of the official start of summer. Per a press release from Aldi, shoppers can expect to see savings on hundreds of seasonal essentials such as fresh meat for the grill, organic produce, pantry staples, and more. The savings are slated to impact more than 400 items overall, across all of Aldi's 2,400+ stores nationwide. According to Aldi's chief commercial officer, Scott Patton, prices on the aforementioned products will be reduced by as much as 33%, and this price cut will remain in effect from now until Labor Day. 'Our customers count on Aldi for the lowest prices of any national grocer, every day, and we never take that trust for granted,' Jason Hart, Aldi CEO, said in a statement. 'While customers may see higher prices at other retailers, we're working hard to unlock even more value for our shoppers, just in time for summer's lineup of holidays and gatherings where food takes center stage. It's another way we're doubling down on our commitment to help shoppers fill their carts with great products for less.' Aldi estimates that by drastically reducing prices on hundreds of items, customers will save a whopping $100 million this summer. 'This summer, we're going further to deliver more of what sets us apart, great products at the lowest possible prices,' Patton shared in a statement. 'With price drops on the season's most-loved products in every aisle, we want to do what we can to help shoppers enjoy more of summer.'To find items on sale this summer, look for the red price drops logo while exactly what products will customers save on this summer? Here are a few items that are currently on sale: Clancy's Hot Chili Lime Flavored Potato Chips: reduced from $1.89 to $1.79 Simply Nature Organic Grass Fed 85% Lean Ground Beef: reduced from $5.99 to $4.99 Friendly Farms 2% Reduced Fat Ultra-Filtered Milk: reduced from $4.39 to $3.89 Millville Chocolate Chip Protein Pancake & Waffle Mix: reduced from $3.79 to $3.49. Mama Cozzi's Pizza Kitchen Pepperoni Pizza Bagels: reduced from $6.29 to $5.99. Summit Popz Cherry Lime Flavored Prebiotic Soda: reduced from $1.59 to $1.49. Southern Grove Dried Philippine Mango: reduced from $4.09 to $3.49 Simply Nature Sprouted 7 Grain Bread: reduced from $4.09 to $3.49 Pink Lady Apples, 3 lbs.: reduced from $3.95 to $3.49 Read the original article on Real Simple Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
